DOC

Form 3

By Harold Carpenter,2014-06-27 10:25
6 views 0
Form 3 ...

    Updated version December 2007

    Form 3

    Renomination of Methyl Bromide Critical use for Structures, Commodities or Objects

SUMMARY PAGE

NOMINATING PARTY:

    NAME AS PER NAMING CONVENTION (Section 3.5.2 of this Handbook)

BRIEF DESCRIPTIVE TITLE OF NOMINATION:

STRUCTURE, COMMODITY OR OBJECT TREATED:

    QUANTITY OF METHYL BROMIDE REQUESTED IN EACH YEAR OF NOMINATION:

    SUMMARY OF ANY SIGNIFICANT CHANGES SINCE SUBMISSION OF PREVIOUS NOMINATIONS:

     1

    Updated version December 2007 Details on this page are similar to those for new nominations requested under

    Decision Ex. I/4(7), for posting on the Ozone Secretariat website under Decision Ex.

    I/4(8)

This form is to be used by holders of single-year exemptions to reapply for a

    subsequent year’s exemption for Structures, Commodities and Objects only (for

    example, a Party holding a single-year exemption for 2006 and/or 2007 seeking

    further exemptions for 2008). It does not replace the format for requesting a critical-

    use exemption for the first time.

In assessing nominations submitted in this format, TEAP and MBTOC will also refer

    to the original nomination on which the Party’s first-year exemption was approved, as

    well as any supplementary information provided by the Party in relation to that

    original nomination. As this earlier information is retained by MBTOC, a Party need

    not re-submit that earlier information.

NOMINATING PARTY CONTACT DETAILS:

    Contact Person: Title: Address (include

    city/code numbers):

    Telephone: Fax: E-mail:

    Following the requirements of Decision IX/6 paragraph (a)(1) [insert name of Party] has determined that the specific use detailed in this Critical Use Nomination is critical

    because the lack of availability of methyl bromide for this use would result in a

    significant market disruption.

     ? Yes ? No

     2

    Updated version December 2007

Signature Name Date

    Title:

CONTACT OR EXPERT(S) FOR FURTHER TECHNICAL DETAILS

    Contact/Expert Person: Title: Address (include

    city/code numbers):

    Telephone: Fax:

     E-mail:

LIST OF DOCUMENTS SENT TO THE OZONE SECRETARIAT IN

    OFFICIAL NOMINATION PACKAGE

List all paper and electronic documents submitted by the Nominating Party to the

    Ozone Secretariat.

    1. PAPER DOCUMENTS: Title of paper documents and No. of pages Date sent to appendices Ozone

    Secretariat

     3

    Updated version December 2007

    2. ELECTRONIC COPIES OF ALL PAPER No. of Date sent to DOCUMENTS: ) kilobytes Ozone

    Secretariat

     4

    Updated version December 2007

    Part A: SUMMARY INFORMATION

    1. NOMINATING PARTY AND NAME AS PER NAMING CONVENTION

    Para 3.5.2 of Handbook:

    2. BRIEF DESCRIPTIVE TITLE OF NOMINATION:

    3. YEAR FOR WHICH EXEMPTION SOUGHT:

    4. SUMMARY OF ANY SIGNIFICANT CHANGES SINCE SUBMISSION OF

    PREVIOUS NOMINATIONS

    (e.g. changes to requested exemption quantities, successful trialling or commercialisation of

    alternatives, etc.)

Part B: TRANSITION PLANS

Provision of a National Management Strategy for Phase-out of Methyl Bromide is a requirement

    under Decision Ex. I/4(3) for nominations after 2005. The time schedule for this Plan is different

    than for CUNs. Parties may wish to submit Section 21 separately to the nomination.

    5. IF NOT ALREADY PROVIDED, DESCRIBE MANAGEMENT STRATEGIES

    THAT ARE IN PLAVE OR PROPOSED TO ELIMINATE THE USE OF

    METHYL BROMIDE FOR THE NOMINATED CRITICAL USE INCLUDING:

(1) Measures to avoid any increase in methyl bromide consumption except for unforeseen

    circumstances;

    (2) Measures to encourage the use of alternatives through the use of expedited procedures,

    where possible, to develop, register and deploy technically and economically feasible

    alternatives;

     5

    Updated version December 2007

    (3) Provision of information on the potential market penetration of newly deployed

    alternatives and alternatives which may be used in the near future, to bring forward the

    time when it is estimated that methyl bromide consumption for the nominated use can be

    reduced and/or ultimately eliminated;

    (4) Promotion of the implementation of measures which ensure that any emissions of methyl

    bromide are minimized;

    (5) Actions to show how the management strategy will be implemented to promote the

    phase-out of uses of methyl bromide as soon as technically and economically feasible

    alternatives are available, in particular describing the steps which the Party is taking in

    regard to subparagraph (b) (iii) of paragraph 1 of Decision IX/6 in respect of research

    programmes in non-Article 5 Parties and the adoption of alternatives by Article 5 Parties.

Part C: TRANSITION ACTIONS

Responses should be consistent with information set out in the applicant’s previously-approved

    nominations regarding their transition plans, and provide an update of progress in the

    implementation of those plans.

In developing recommendations on exemption nominations submitted in 2003, 2004, 2005 and

    2006, the Technology and Economic Assessment Panel in some cases recommended that a Party

    should explore the use of particular alternatives not identified in a nomination’ transition plans.

    Where the Party has subsequently taken steps to explore use of those alternatives, information

    should also be provided in this section on those steps taken.

Questions 6 - 10 should be completed where applicable to the nomination. Where a question is

    not applicable to the nomination, write “N/A”.

    6. TRIALS OF ALTERNATIVES

Where available, attach copies of trial reports. Where possible, trials should be comparative,

    showing performance of alternative(s) against a methyl bromide-based standard

    i. Description and implementation status:

    ii. Outcomes of trials:

Include any available data on outcomes from trials that are still underway. Where applicable,

    complete the table included at Appendix I identifying comparative disease ratings and yields with the use of methyl bromide formulations and alternatives.

     6

    Updated version December 2007

    iii. Impact on critical use nomination/required quantities:

For example, provide advice on any reductions to the required quantity resulting from successful

    results of trials.

    iv. Actions to address any delays/obstacles in conducting or finalising trials:

    7. TECHNOLOGY TRANSFER, SCALE-UP, REGULATORY APPROVAL FOR

    ALTERNATIVES

    i. Description and implementation status:

    ii. Outcomes achieved to date from technology transfer, scale-up, regulatory

    approval:

    iii. Impact on critical use nomination/required quantities:

For example, provide advice on any reductions to the required quantity resulting from successful

    progress in technology transfer, scale-up, and/or regulatory approval.

     7

    Updated version December 2007

    iv. Actions to address any delays/obstacles:

    8. COMMERCIAL SCALE-UP /DEPLOYMENT, MARKET PENETRATION OF

    ALTERNATIVES

    i. Description and implementation status:

    ii. Impact on critical use nomination/required quantities:

For example, provide advice on any reductions to the required quantity resulting from successful

    commercial scale-up/deployment and/or market penetration.

    iii. Actions to address any delays/obstacles:

    9. CHANGES TO TRANSITION PROGRAM

If the transition program outlined in the Party’s original nomination has been changed, provide

    information on the nature of those changes and the reasons for them. Where the changes are

    significant, attach a full description of the revised transition program.

    10. OTHER BROADER TRANSITION ACTIVITIES

Provide information in this section on any other transitional activities that are not addressed

    elsewhere. This section provides a nominating Party with the opportunity to report, where

    applicable, on any additional activities which it may have undertaken to encourage a transition,

    but need not be restricted to the circumstances and activities of the individual nomination.

    Without prescribing specific activities that a nominating Party should address, and noting that

     8

    Updated version December 2007

    individual Parties are best placed to identify the most appropriate approach to achieve a swift

    transition in their own circumstances, such activities could include market incentives, financial

    support to exemption holders, labelling, product prohibitions, public awareness and information

    campaigns, etc.

     9

    Updated version December 2007

    Part D: REGISTRATION OF ALTERNATIVES

Progress in registration of a product will often be beyond the control of an individual exemption

    holder as the registration process is the responsibilityof the manufacturer or supplier of the

    product. The speed with which registration applications are processed also can falls outside the

    exemption holder’s control, resting with the nominating Party. Consequently, this section requests the nominating Party to report on any efforts it has taken to assist the registration

    process, but noting that the scope for expediting registration will vary from Party to Party.

    11. PROGRESS IN REGISTRATION

Where the original nomination identified that an alternative’s registration was pending, but it

    was anticipated that one would be subsequently registered, provide information on progress with

    its registration. Where applicable, include any efforts by the Party to “fast track” or otherwise

    assist the registration of the alternative.

    12. DELAYS IN REGISTRATION

Where significant delays or obstacles have been encountered to the anticipated registration of an

    alternative, the exemption holder should identify the scope for any new/alternative efforts that

    could be undertaken to maintain the momentum of transition efforts, and identify a time frame for

    undertaking such efforts.

    13. DEREGISTRATION OF ALTERNATIVES

Describe new regulatory constraints that limit the availability of alternatives. For example,

    changes in buffer zones, new township caps, new safety requirements (affecting costs and

    feasibility), and new environmental restrictions such as to protect ground water or other natural

    resources. Where a potential alternative identified in the original nomination’s transition plan

    has subsequently been deregistered, the nominating Party would report the deregistration

    including reasons for it. The nominating Party would also report on the impact of the

    deregistration (if any) on the exemption holder’s transition plan and on the proposed new or

    alternative efforts that will be undertaken by the exemption holder to maintain the momentum of

    transition efforts.

     10

Report this document

For any questions or suggestions please email
cust-service@docsford.com